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Abstract 
 
Background: This study examined the quality of life (QOL), measured by the Functional 
Assessment of Cancer Therapy (FACT) questionnaire, among urban (n=277) and non-urban 
(n=323) breast cancer survivors and women from the general population (n=1140) in 
Queensland, Australia.  
Methods: Population-based samples of breast cancer survivors aged <75 years who were 12 
months post-diagnosis and similarly-aged women from the general population were recruited 
between 2002 and 2007.  
Results: Age-adjusted QOL among urban and non-urban breast cancer survivors was similar, 
although QOL related to breast cancer concerns was the weakest domain and was lower 
among non-urban survivors than their urban counterparts (36.8 versus 40.4, P<0.01). 
Irrespective of residence, breast cancer survivors, on average, reported comparable scores on 
most QOL scales as their general population peers, although physical well-being was 
significantly lower among non-urban survivors (versus the general population, P<0.01). 
Overall, around 20%-33% of survivors experienced lower QOL than peers without the 
disease. The odds of reporting QOL below normative levels were increased more than two-
fold for those who experienced complications following surgery, reported upper-body 
problems, had higher perceived stress levels and/or a poor perception of handling stress 
(P<0.01 for all).  
Conclusions: Results can be used to identify subgroups of women at risk of low QOL and to 
inform components of tailored recovery interventions to optimize QOL for these women 
following cancer treatment. 
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Background 
Breast cancer is a major public health concern, with one in eight women developing the 
disease before the age of 85 years in developed countries of the world [1, 2]. Despite 
therapeutic advances, which have contributed to improvements in survival (five-year survival 
currently 87%) [3] women continue to experience considerable physical and psychosocial 
dysfunction during and following treatment. While these quality of life (QOL) concerns are 
short-lived for some, others may struggle to regain expected levels of QOL longer term. 
 
QOL has been associated with adherence to treatment [4] and prognosis [5, 6] and is now 
recognized as an important research outcome. International research on factors that influence 
QOL among breast cancer survivors has been extensive (over 300 published studies in 2008 
alone integrated QOL as an outcome). Socio-demographic (e.g., income), general health (e.g., 
medical conditions) and treatment (e.g., adjuvant therapy) characteristics each have been 
associated with QOL [7], with the strength and consistency of the associations dependent on 
the characteristic of interest. Nevertheless, there remain subgroups of women for whom 
limited information on QOL is available, including those women who reside outside major 
metropolitan areas. This is important because approximately one-third of new breast cancer 
cases live outside major metropolitan areas [2]. 
 
In Australia, geographic residence influences stage at diagnosis and type of surgery, with 
those living in rural areas more likely to have a mastectomy than their urban counterparts 
(38% versus 25%, respectively) [8-10]. Geographic residence also influences access to health 
services [11], as fewer than half of regional/rural hospitals administer chemotherapy [12], and 
fewer still provide radiotherapy services [13]. Further, rural Australian women often have to 
travel in excess of 100 kilometers (i.e., 62 miles) to receive adjuvant treatment and are away 
from home for approximately 20 to 43 days for chemotherapy and radiotherapy treatment, 
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respectively [14, 15]. Hence, it seems plausible that rural women with breast cancer may have 
unique and additional burdens, such as disruption to family life, work and financial security 
[14, 16], which ultimately may influence QOL differently to that observed for women 
residing in urban areas. 
 
Research that compares QOL between urban and non-urban cancer survivors is lacking, and 
from those studies that exist, results are inconsistent. Two studies suggest that rural breast 
cancer survivors fare worse [17, 18], while one indicates that QOL is superior among a rural 
group of mixed cancer survivors [19], when compared with their urban counterparts. Further, 
there is a paucity of information comparing the QOL among cancer groups with that of the 
general population, making interpretation of findings challenging. Therefore, this paper 
examines whether QOL differs between urban and non-urban women 12 months following 
breast cancer diagnosis and compares their QOL with women from the general population 
residing in their respective geographic areas. We also sought to identify characteristics of 
breast cancer survivors associated with reporting QOL below normative levels. 
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Methods 
Breast cancer study samples 
The Pulling Through Study (PTS) was a longitudinal, population-based study among breast 
cancer survivors living within 100 kilometers (i.e., 62 miles) of the capital city of Brisbane in 
Queensland, Australia, and diagnosed in 2002 [20, 21]. This study was extended to include 
survivors from non-urban areas of Queensland, diagnosed between April 2006 and March 
2007 [22]. The Accessibility/Remoteness Index of Australia (ARIA+) classification system 
was used to define place of residence as either major city, inner regional, outer regional, 
remote or very remote, and is based on road distance and population size of the nearest town 
[23]. The selected localities within the perimeter of Brisbane fall within the ARIA+ 
classification for major cities and hereafter are referred to as ‘urban’. Residents of inner 
regional, remote and very remote areas were pooled as the ‘non-urban’ group and reflect the 
reduced access to a range of oncology services experienced by those who live outside state 
capital cities, irrespective of the level of remoteness [12]. 
 
Eligible women, diagnosed with unilateral breast cancer at age 74 years or younger, were 
randomly selected through the Queensland Cancer Registry (target sample). All cancer 
diagnoses in Queensland are required to be reported to the Registry and therefore these 
records provide an accurate sampling frame for recruitment. Since breast cancer is mostly a 
disease of women 50yrs or older and to ensure adequate numbers were available for specific 
age group analyses, younger women were over-sampled in the urban arm of the study, while 
100% of eligible non-urban women were recruited for all age groups. Following appropriate 
ethical approval and the requirements of the cancer registry, doctor consent to contact eligible 
women (provided for 82% of the urban sample and 90% of the non-urban sample) and 
participant consent was sought. Overall, 277 urban and 323 non-urban women returned 
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completed questionnaires at 12 months post-diagnosis (66% and 71% of eligible women with 
doctor consent for the urban and non-urban arms, respectively). 
 
General population study sample 
Following ethical approval, the general Queensland population sample was derived from the 
Queensland Cancer Risk Study (QCRS), a population-based survey conducted in 2004 among 
English-speaking residents of Queensland, aged 20-75 years, randomly sampled within strata 
defined by gender, age and geographic region (defined by the ARIA+ classification as as 
major city, inner regional, outer regional or remote/very remote). Further details about the 
study methods are described elsewhere [24]. Briefly, of the 8,398 adults who agreed to 
participate in the self-administered questionnaire, 5822 (69.3%) returned surveys, of which 
2727 contained QOL information. Analyses reported in this paper include women for whom 
QOL data were available and who had no prior history of breast cancer, with 675 living in 
urban and 465 in non-urban areas of Queensland, as defined by the ARIA+. 
 
Questionnaires 
QOL was measured among women with breast cancer at 12 months post-diagnosis using the 
Functional Assessment of Cancer Therapy (FACT-G) questionnaire, which is comprised of 27 
items rated on a five-point Likert scale (ranging from 0=’not at all’ to 4=’very much’) and 
includes four subscales (physical, social, emotional, and functional well-being). Higher scores 
represent better well-being. Women in the QCRS received the general population FACT 
instrument (FACT-GP), which is identical to the FACT-G except it excludes six illness-
related items inappropriate for the general population [25, 26]. Overall FACT-GP summary 
scores and subscales were pro-rated as per the FACT manual to obtain scores comparable to 
the FACT-G [27], resulting in total scores for all study groups ranging from 0-108 for overall 
QOL, 0-28 for the physical, social, and functional well-being subscales, and 0-24 for the 
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emotional well-being subscale. Women with breast cancer also completed 13 questions on 
breast cancer concerns and arm morbidity (FACT-B+4), with total scores from 0-52 for the 
breast cancer concerns subscale, and 0-160 for overall FACT-B+4. The FACT instrument has 
excellent reliability and validity [28]. 
 
Demographic (age, marital status, educational level, private health insurance, occupation [29, 
30] and income), general health (smoking status, body mass index, co-morbidities, 
complications following surgery, upper-body function [31], physical activity and stress levels 
including perceived handling of stress) and treatment (chemotherapy, radiotherapy, hormone 
therapy) characteristics for the breast cancer study participants were also obtained via the 
questionnaire, whereas information on tumor characteristics were abstracted from 
histopathology reports (e.g., type of surgery, maximum tumor size and grade, and lymph node 
status). 
 
Statistical analysis 
Distributions of the FACT scores were approximately normal and hence were summarized as 
means with 95% confidence intervals (CIs) using SPSS (SPSS Inc, Chicago, IL, version 14). 
Analysis of variance tests compared age-adjusted mean QOL scores at 12 months post-
diagnosis between urban and non-urban breast cancer survivors. Comparisons between breast 
cancer survivors and women from the general population involved general linear regression 
models to obtain QOL scores adjusted for characteristics that differed between the groups 
(i.e., potential confounding factors). 
 
Descriptive results presented in this study have been adjusted for the sampling fraction used 
to identify younger breast cancer patients from urban areas (weighting applied: <50 years:1.0; 
>50 years:1.3). The general population comparison group was also weighted by age, based on 
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Australian Bureau of Statistics data, so that results reflect the actual female Queensland 
resident population (weighting applied for urban, regional, outer regional, remote and very 
remote: <50 years:1.3, 1.3, 1.4, 1.5 and 0.9, respectively; >50 years:0.8, 0.8, 0.7, 0.6 and 1.1, 
respectively) [33]. The conventional P<0.05 level (two-tailed) was accepted as statistically 
significant. Differences of eight or more points in mean FACT-B+4 scores, five or more 
points in mean FACT-G scores, three or more points on the breast cancer concerns subscale 
and two or more points for all other subscales between urban and non-urban breast cancer 
survivors or between women with breast cancer and their general population peers were 
considered clinically important, as recommended by developers of the FACT [25]. For 
correlates, a difference in odds ratios (ORs) of >1.8 or <0.6 was considered to be of potential 
clinical relevance. 
 
As suggested by Fayers [34], a new outcome measure was calculated to characterize breast 
cancer survivors whose QOL was below normative levels. QOL values were calculated for 
each five-year age stratum of the general population study group and subtracted from the 
QOL score within the same age group of women with breast cancer (i.e., case FACT-G minus 
general population comparison group FACT-G) separately by urban and non-urban residence 
[34]. Positive scores indicate higher QOL, and negative scores indicate lower QOL, among 
cases relative to age- (within five years) and residence-matched peers. Relative overall QOL 
(FACT-G) was then categorized into groups using score differentials considered clinically 
important to investigate the proportions of breast cancer survivors with relative overall QOL 
lower than (-5.0 points or more), similar to (>-5.0 to <+5.0) or better than (+5.0 points or 
more) the general population study group. Relative QOL was also calculated for each 
subscale, using two points as the critical threshold. A dichotomous outcome variable was 
defined, combining the ‘similar’ and ‘better’ groups, and binary logistic regression was used 
to generate ORs and 95% CIs to identify demographic, general health, and clinical 
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characteristics associated with QOL status below the norm compared to the ‘similar/better’ 
group. A range of potentially important correlates were explored, however, only those that 
were found to be statistically significant or clinically important are reported. Formal tests of 
interactions between residence and each of the characteristics of interest did not yield any 
statistically significant results, therefore pooled results, adjusted for residence, are presented. 
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Results 
Sample characteristics 
Demographic and disease characteristics were similar for the women with breast cancer in this 
study and those in the target sample. The majority of women (75-80%) were diagnosed with 
infiltrating ductal carcinoma, approximately 60% received complete local excision of their 
tumour and more than 50% had 10 or more lymph nodes removed. However, participants 
among urban breast cancer survivors had somewhat smaller tumor size (median tumour size 
was 14mm) when compared with the target sample [20-22]. For the majority of demographic 
and general health characteristics, women with breast cancer had similar characteristics, 
irrespective of place of residence. However, the urban compared to the non-urban breast 
cancer sample was more likely to be unmarried, have private health insurance and report 
fewer co-morbidities, and less likely to be obese (Table 1). Non-urban compared to urban 
women with breast cancer were more likely to have multiple forms of adjuvant therapy and 
less likely to report multiple complications. 
 
A comparison of women with or without breast cancer showed significant differences for 
several demographic and general health characteristics (Table 1). Breast cancer survivors 
tended to be older or have lower educational levels when compared with the general 
population, irrespective of residence. In addition, urban breast cancer survivors were more 
likely to be single, have private health insurance, and/or fewer co-morbidities (other than 
breast cancer), while non-urban breast cancer survivors were more likely to be sedentary 
and/or have two or more co-morbidities (other than breast cancer), when compared with their 
general population counterparts. While there was a significant (P<0.05) difference in body 
mass index between urban breast cancer survivors and their general population peers, this was 
attenuated when missing values were omitted from analyses. 
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QOL among urban and non-urban breast cancer survivors 
Although urban breast cancer survivors reported higher age-adjusted QOL summary and 
subscale scores than their non-urban counterparts 12 months following diagnosis, differences 
did not reach the threshold for clinical importance even for those subscales that were 
statistically significant (physical, emotional, and overall QOL, P<0.01). In contrast, well-
being related to breast cancer concerns was lower among non-urban compared to urban 
survivors by statistical (P<0.01) and clinical criteria (Table 2). Furthermore, for both groups, 
women reported most detriment to their QOL for this subscale, with participants reporting 
mean values below 80% of the maximum score on average. Participants reported mean values 
at approximately 80% of the maximum score for all other subscales. 
 
Breast cancer survivors’ QOL compared to the general population 
Table 3 presents the subscale and overall mean FACT-G scores for breast cancer survivors 
compared with women from the general population, stratified by residence and adjusted for 
potential confounding factors. At 12 months post-diagnosis, urban and non-urban breast 
cancer survivors reported clinically higher social well-being compared with their general 
population peers, and non-urban breast cancer survivors also reported clinically lower 
physical well-being (P<0.01 for all). Scores for emotional, functional and overall (FACT-G) 
QOL were clinically comparable to their counterparts from the general population despite a 
statistically significant difference for emotional and functional well-being (P<0.01). 
 
Using the new outcome measure of QOL relative to age and residency-matched women from 
the general population, depending on the specific QOL scale, between 17.2% and 32.8% of all 
women with breast cancer reported clinically lower QOL 12 months following diagnosis than 
age- (within five years) and residence-matched women without the disease. A further 17.5%-
48.5% of women reported similar QOL, while the remainder (19.8%-65.3%) reported 
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clinically better QOL (Figure 1). The subscales with the highest proportions below the norm 
were emotional (32.8%) and physical (29.3%) well-being, and overall QOL (26.2%). 
 
Characteristics associated with QOL below normative levels among breast cancer 
survivors 
Following adjustment for potential confounding factors, a range of characteristics were 
associated with breast cancer survivors reporting overall (FACT-G) QOL below normative 
levels (Table 4), but place of residence (i.e., urban versus non-urban) was not one of these 
(Odds Ratio (OR)=1.06; 95% Confidence interval (CI)=0.64-1.74). Experiencing one or more 
complications following surgery was associated with two-fold increased odds (OR=2.26, 95% 
CI=1.31-3.90; P<0.01) of reporting reduced QOL, while upper-body function below the 
median, moderate or higher stress levels and poor perceived handling of stress were each 
associated with at least four-fold increased odds of reporting reduced QOL (ORs ranging 
from 4.24-4.77, P<0.01, see Table 4). A marker of higher socioeconomic status, having 
private health insurance, was associated with a 0.6 odds of reporting lower relative QOL 
(95% CI = 0.37-0.99, P=0.05). 
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Discussion 
Urban and non-urban breast cancer survivors reported similar levels of QOL 12 months 
following diagnosis, overall and for subscales. The sole exception was the breast cancer 
concerns subscale, which showed that non-urban residents fared worse than their urban 
counterparts. When comparing breast cancer survivors to age- and residence-matched peers, 
the only detriment to QOL was among non-urban breast cancer survivors who reported 
statistically and clinically poorer physical well-being. Overall, up to one in three breast cancer 
survivors reported QOL below the age- and residency-matched general female population. 
The major independent correlates of reporting overall QOL below that of age-matched 
women without breast cancer were complications following surgery, poorer upper-body 
function, higher perceived stress levels, and poor perception of handling stress. 
 
Despite the known differences by geographic residence with regards to access to services, 
availability of treatment and survival outcomes, our results indicate only minor disparities in 
QOL between urban and non-urban breast cancer survivors 12 months post-diagnosis. The 
subscale measuring breast cancer-specific concerns yielded the lowest values (based on 
percent of maximum score) reported by all survivors, but in particular for women living in 
non-urban areas. Items within this subscale deal with treatment-related symptoms, such as 
swelling of the arms, pain, shortness of breath, body image and sexuality. These results 
support existing research which demonstrates that while QOL among breast cancer survivors 
improves considerably during the first year following completion of treatment, breast cancer 
treatment-related concerns (such as arm dysfunction, poor body image, and sexual 
dysfunction) may persist [35-39]. 
 
It is plausible that non-urban survivors suffer in terms of their breast cancer-specific QOL, 
more so than urban survivors, as a consequence of inequalities in accessing specialised 
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services. However, study-specific data collection procedures may also have contributed. QOL 
scores were derived from the third questionnaire for participants in the longitudinal urban 
breast cancer study, whereas the first (and only) questionnaire was the source of QOL data for 
non-urban breast cancer participants. Therefore urban survivors may have responded 
differently to QOL questions over time, not only because their QOL changed, but also 
because they may have become used to answering questions about QOL and might have over 
time changed their perception of QOL. This response shift may, in part, explain what appears 
to be a more positive breast cancer-specific QOL among urban survivors than non-urban 
survivors. However, the difference in QOL was observed on most but not all subscales, 
suggesting that response shift played a minor role in our findings. 
 
On average, QOL was similar for breast cancer survivors and general population peers, for 
both urban and non-urban residents, similar to results reported by other authors studying QOL 
among breast cancer survivors 12 months [40, 41] or longer [18, 26, 42] following diagnosis. 
The high FACT-G scores observed among breast cancer survivors are somewhat surprising, 
because patients frequently report ongoing symptoms and long-term side-effects [35, 36, 39]. 
High functional and social well-being reported by breast cancer survivors compared to their 
general population counterparts contributed to their overall high FACT-G score and 
contradicts previous research [18, 26, 40-42]. However, the literature is dominated by studies 
using the European Organisation for the Research and Treatment of Cancer QOL 
questionnaire (EORTC QLQ-C30) [18, 26, 40, 41]. The social well-being subscale of the 
EORTC QLQ-C30 and the FACT have been shown to be poorly correlated (r=0.09) [43] 
suggesting they measure different aspects of social well-being. Furthermore, QOL domains 
measured by the FACT-G may be more relevant to short-term recovery. Whereas 12 months 
or longer after diagnosis, alternate issues may become more important for QOL, such as fear 
of recurrence or making meaning of the cancer experience. More recently, survivorship-
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specific QOL instruments have been developed, and further research is needed to assess 
whether these will uncover additional medium- to long-term survivorship issues [44]. 
 
Despite overall QOL similarities between survivors and their general population peers, up to 
one-third (depending on the subscale) of survivors continued to experience lower QOL 12 
months following diagnosis of breast cancer. To our knowledge, despite Fayers suggesting 
advanced analytical procedures using normative scores in 2000 [34], this is the first study to 
assess correlates of lower QOL among breast cancer survivors in this manner. The results 
demonstrate that experiencing one or more treatment-related complications, reporting lower 
upper-body function than the median, moderate to high stress levels and/or perceived poor 
handling of stress could reduce the odds of good QOL two- to four-fold. The cross-sectional 
nature of the data denotes that these characteristics are correlates of QOL but not necessarily 
causes. Moreover, the relative QOL index used to identify these correlates may be focusing 
on those women with breast cancer who would have been in the lower part of the QOL range 
even before they had the disease. Regardless, these correlates have relevance for identifying 
subgroups of breast cancer survivors who require assistance to regain QOL to levels expected 
among age-matched peers from the general population. 
 
Several key design features of this work highlight the strength and importance of the findings. 
Results were obtained from population-based urban and non-urban breast cancer samples, 
representative of their respective target populations [20-22], and therefore results are likely 
generalizable to the wider population of breast cancer survivors. Further, QOL of survivors 
were compared to peers without breast cancer, including matching for place of residence, 
allowing for more accurate interpretation of meaning of results. At a glance, the results from 
this study suggest that, overall, women with breast cancer fare well by 12 months following 
diagnosis; however, interventions are needed to improve breast cancer-related concerns 
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among all women with breast cancer and physical well-being among non-urban survivors. 
These should specifically recruit those survivors who experience complications following 
surgery, upper-body dysfunction and/or those with a greater burden of stress (i.e., higher 
amounts and/or poor self-perceived handling of stress). Interventions that address such 
concerns and that are accessible for all women, irrespective of place of residence, may help 
facilitate a faster return to optimal QOL in the future. 
 
Conclusions 
Overall, the QOL of breast cancer survivors living in rural and urban areas was similar except 
for breast cancer related concerns being more dominant in women from rural locations. 
Among all women about 20%-33% have lower QOL one year past diagnosis compared to age 
matched women from the general population without breast cancer and thus could benefit 
from additional support and interventions.  
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Figures 
Figure 1. Proportions of breast cancer survivors whose relative QOL at 12 months 
post-diagnosis was lower than, similar to, or better than general population peers 
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Table 1. Participant Characteristics  
Characteristics 
Urban general 
populationa 
(n=675) 
 
Urban breast 
cancer survivorsb 
(n=277) 
 Non-urban general 
populationa 
(n=465) 
 
Non-urban breast 
cancer survivors 
(n=323) 
n %  n %  n %  n % 
Demographic characteristics            
Age (years) 
 <50 
 50+ 
 
 298 
 377 
 
57.0 
43.0 
  
 99 
 178 
* 
30.0 
70.0 
 
 
 185 
 280 
 
55.6 
44.4 
  
 107 
 216 
 
33.1 
66.9 
Marital status 
 Married, or living as married 
 Not married 
 
 520 
 155 
 
77.6 
22.4 
  
 186 
 91 
* 
66.6 
33.4 
 
 
 361 
 104 
 
80.1 
19.9 
  
 248 
 75 
†
76.8 
23.2 
Education level 
 Grade 10 or below 
 Grade 12/Trade/TAFE 
 University or college degree 
 
 219 
 278 
 178 
 
30.2 
42.5 
27.3 
  
 125 
 95 
 57 
* 
46.5 
33.7 
19.9 
 
 
 186 
 183 
 96 
 
37.0 
40.7 
22.3 
  
 173 
 102 
 48 
* 
53.6 
31.6 
14.9 
Private health insurance status 
 Yes 
 No 
 
 398 
 277 
 
58.0 
42.0 
  
 200 
 77 
* 
72.4 
27.6 
 
 
 222 
 243 
 
48.5 
51.5 
  
 140 
 183 
†
43.3 
56.7 
General health characteristics           
Smoking status 
 Never smoked 
 Past smoker 
 Current smoker 
 
 364 
 216 
 95 
 
53.6 
31.2 
15.2 
  
 163 
 84 
 30 
 
59.3 
30.0 
10.7 
 
 
 250 
 149 
 66 
 
52.9 
31.7 
15.3 
  
 184 
 102 
 37 
 
57.0 
31.6 
11.5 
Physical activityc 
 Sedentary 
 Insufficient activity 
 Sufficient activity 
 
 94 
 194 
 387 
 
17.5 
27.9 
54.6 
  
 34 
 67 
 176 
 
12.6 
23.9 
63.5 
 
 
 81 
 125 
 259 
 
13.7 
29.4 
57.0 
  
 68 
 55 
 200 
* 
21.1 
17.0 
61.9 
Body mass index (kg/m2) 
 Underweight/Normal (up to 24.9) 
 Overweight (25-29.9) 
 Obese (30+) 
 Missing 
 
 335 
 203 
 106 
 31 
 
41.5 
27.4 
25.1 
6.0 
  
 108 
 80 
 55 
 34 
* 
38.5 
29.0 
20.0 
12.5 
 
 
 183 
 134 
 119 
 29 
 
50.7 
29.6 
14.9 
4.7 
  
 116 
 91 
 100 
 16 
†
35.9 
28.2 
31.0 
5.0 
Number of co-morbiditiesd 
 None 
 One 
 Two 
 Three or more 
 
 126 
 158 
 133 
 258 
 
21.6 
19.0 
19.7 
39.6 
  
 68 
 68 
 69 
 72 
* 
23.8 
23.7 
25.6 
27.0 
 
 
 84 
 79 
 95 
 206 
 
21.4 
24.7 
19.2 
34.7 
  
 55 
 74 
 79 
 115 
*†
17.0 
22.9 
24.5 
35.6 
Clinical characteristics            
Adjuvant treatment 
 None 
 Chemotherapy only 
 Radiotherapy only 
 Both 
- -   
42 
34 
119 
82 
 
15.8 
11.3 
43.8 
29.1 
 
- -   
59 
33 
105 
126 
†
18.3 
10.2 
32.5 
39.0 
Number of complicationse 
 None 
 Yes, one to four 
- -   
54 
223 
 
19.7 
80.3 
 
- -   
133 
190 
†
41.2 
58.8 
Abbreviations: 
* Statistically significant difference (P<0.05) between the general population and breast cancer survivors by place of location. 
† Statistically significant difference (P<0.05) between urban and non-urban breast cancer survivors. 
Notes: 
(a) Column percentages are standardized to the 2003 Queensland population by age. 
(b) Column percentages have been weighted to correct for sampling. 
(c) ‘Sedentary’ is defined as no activity; ‘Insufficient’ time is defined as participating in some activity but less than 150 minutes per 
week, using the sum of walking, moderate activity and vigorous activity (weighted by 2); ‘Sufficient’ time is defined as 150 minutes 
per week, using the sum of walking, moderate activity and vigorous activity (weighted by 2) [45].  
(d) Co-morbidities include heart conditions, high blood pressure, high cholesterol, stroke, diabetes, lung conditions, stomach or 
duodenal ulcer, migraine or headaches, arthritis, cancer other than breast, depression and other prolonged or serious illness. 
(e) Complications include wound infection, other infection, skin reaction, seroma. 
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Table 2. QOL scores at 12 months post-diagnosis for urban and non-urban breast cancer 
survivors 
Quality of life 
 Urban breast cancer 
survivors (n=277) 
 
Non-urban breast cancer 
survivors (n=323) 
 
Differences between 
residence groups 
 Meana 95% CI  Meana 95% CI  P-Value clinicalb
Physical well-being (0-28)  24.7 24.1, 25.2  22.8 22.3, 23.3  <0.01  
Social well-being (0-28)  22.7 22.0, 23.4  22.5 21.8, 23.1  0.67  
Emotional well-being (0-24)  20.1 19.6, 20.5  19.2 18.7, 19.6  <0.01  
Functional well-being (0-28)  22.4 21.8, 23.1  21.7 21.1, 22.3  0.09  
Breast cancer concerns (0-52)  40.4 39.5, 41.4  36.8 36.0, 37.7  <0.01  
FACT-G (0-108)  89.7 87.9, 91.5  86.3 84.7, 88.0  <0.01  
FACT-B+4 (0-160)  130.2 127.7, 132.7  122.6 120.3, 125.0  <0.01  
Abbreviations: 
FACT-G: Functional Assessment of Cancer Therapy-General; FACTB+4: Functional Assessment of Cancer Therapy-Breast additional 
four questions. 
Notes: 
(a) Adjusted for age. 
(b) : clinically meaningful difference between groups (two+ points for physical, social, emotional and functional well-being, three+ 
points for breast cancer concerns, five+ points for FACT-G, eight+ points for FACT-B+4); : no clinically meaningful difference 
between groups.
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Table 3. Adjusted mean QOL for women with breast cancer compared with the general 
population stratified by residence location 
Quality of life Residence General population 
 Breast cancer survivors  Difference between groups 
Meana 95% CI Meana 95% CI  P-Value clinicalb
Physical well-being (0-28) urban 25.0 24.8, 25.3  24.2 23.8, 24.6  <0.01  
 non-urban 25.1 24.7, 25.5  22.7 22.2, 23.2  <0.01  
Social well-being (0-28) urban 19.9 19.5, 20.4  22.4 21.6, 23.2  <0.01  
 non-urban 19.6 19.0, 20.2  22.4 21.7, 23.1  <0.01  
Emotional well-being (0-24) urban 21.1 20.8, 21.4  19.6 19.1, 20.0  <0.01  
 non-urban 20.9 20.5, 21.2  19.2 18.8, 19.7  <0.01  
Functional well-being (0-28) urban 20.6 20.2, 21.1  22.0 21.3, 22.7  <0.01 
 non-urban 20.2 19.7, 20.8  21.6 21.0, 22.3  <0.01  
FACT-G (0-108) urban 86.9 85.8, 88.0  88.0 86.3, 89.8  0.28  
 non-urban 85.8 84.4, 87.3  86.2 84.4, 87.9  0.79  
Abbreviations: 
FACT-G: Functional Assessment of Cancer Therapy-General. 
Notes: 
(a) Adjusted for age (years), marital status (married or living as married, not married), education level (low, moderate, high), private 
health insurance status (yes, no), smoking status (never smoked, past smoker, current smoker), physical activity (sedentary, 
insufficient, sufficient), body mass index (underweight/healthy, overweight, obese, missing), and co-morbidities (none, one, two, three 
or more). 
(b) : clinically meaningful difference between groups (two+ points for physical, social, emotional and functional well-being, five+ 
points for FACT-G); : no clinically meaningful difference between groups.
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Table 4. Correlates of QOL (FACT-G) below the norm at 12 months post-
diagnosis among breast cancer survivorsa 
Characteristics 
 Model
 n ORb 95% CI P-Value 
Place of residence 
 Urban 
 Non-urban  
 
 277 
 323 
 
1.00 
1.06 
 
- 
0.64, 1.74 
0.82 
Age (years) 
 <50 
 50+  
  
 205 
 395 
 
1.00 
0.72 
 
- 
0.43, 1.20 
0.21 
Occupation 
 Professional 
 White-collar worker 
 Blue-collar worker 
 Homemaker 
 Retired/student  
 
 182 
 176 
 31 
 106 
 105 
 
1.00 
1.16 
2.53 
1.29 
0.92 
 
- 
0.64, 2.11 
0.95, 6.76 
0.63, 2.62 
0.43, 1.96 
0.38 
 
 
Yearly income 
 <$52,000 
 $52,000+ 
 Missing 
  
 336 
 207 
 57 
 
1.00 
0.60 
0.66 
 
- 
0.35, 1.04 
0.28, 1.55 
0.15 
 
 
Private health insurance status 
 No 
 Yes  
 
 217 
 383 
 
1.00 
0.61 
 
- 
0.37, 0.99 
0.05 
Overall histological grade 
 Grade 1 
 Grade 2 
 Grade 3 
 Not available  
 
 142 
 219 
 208 
 31 
 
1.00 
0.58 
0.69 
0.54 
 
- 
0.32, 1.06 
0.38, 1.24 
0.14, 2.10 
0.34 
 
 
Number of complicationsc 
 None 
 Yes, one to four  
 
 187 
 413 
 
1.00 
2.26 
 
- 
1.31, 3.90 
<0.01 
Upper-body function 
 Good function (<11) 
 Poor function (11+) 
 Missing  
 
 301 
 258 
 41 
 
1.00 
4.44 
3.63 
 
- 
2.66, 7.40 
1.45, 9.07 
<0.01 
 
 
Amount of stress 
 Very little/some 
 A moderate amount/a lot  
 
 371 
 229 
 
1.00 
4.77 
 
- 
2.93, 7.76 
<0.01 
Perceived handling of stress 
 Very well/fairly well 
 Not well/not well at all  
 
 526 
 74 
 
1.00 
4.24 
 
- 
2.21, 8.15 
<0.01 
Notes: 
(a) Mutually adjusted for all variables in the model. 
(b) Odds ratio for QOL below the norm (R2=0.43). 
(c) Complications include wound infection, other infection, skin reaction, seroma. 
